Amitriptyline capsules - Sun Pharma Advanced Research Company
Alternative Names: SDN - 118Latest Information Update: 28 Aug 2024
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Antidepressants; Antimigraines; Dibenzocycloheptenes; Non-opioid analgesics; Small molecules; Tricyclic antidepressants
- Mechanism of Action Voltage-gated sodium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Major depressive disorder
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for preclinical development in Major depressive disorder in India
- 03 Dec 2020 Chemical structure information added
- 04 Nov 2020 Sun Pharma Advanced Research Company terminates a phase I trial for Major-depressive-disorder (In volunteers) in India prior to initiation (CTRI2020-03-024009 )